No doubt, but as a shareholder it was noted in the financials about the revised timeline, and if one was "high" on the company 3, 6, 9 months ago, a shareholder should be even "higher" on the company today as we fast-approach the one year point past this statement:

"Page 10, Annual Financials:
"Upon facilitation of capital financing agreements erected in Q4 2013, new products and services for consumers and businesses are expected to resume development for enhancing the BudGenius software and data collection platform, including but not limited to, mobile app development, online transparency for laboratory workflow, marijuana genetics and strain mapping, marijuana heritage profiles to highlight sustained and exceptional farmer pedigree, business intelligence data gathering tools, consumer purchase pattern analysis, medical efficacy analysis, loyalty programs, portable diagnostic hardware for patients, and internal tools to optimize company workflow for the purpose of reducing cost of goods sold. A modified release schedule has not yet been determined."